SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001723128-19-000076
Filing Date
2019-05-09
Accepted
2019-05-09 06:42:25
Documents
3
Period of Report
2019-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amrxq12019earningsrelease8.htm 8-K 27536
2 EXHIBIT 99.1 amrxq12019exhibit991.htm EX-99.1 749661
3 exhibit991892018image1a01.jpg GRAPHIC 10129
  Complete submission text file 0001723128-19-000076.txt   792452
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38485 | Film No.: 19808689
SIC: 2834 Pharmaceutical Preparations